| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K16130065 | CTRPv2 | pan-cancer | AAC | 0.37 | 9e-08 |
| mRNA | BRD-K58730230 | CTRPv2 | pan-cancer | AAC | 0.34 | 7e-07 |
| mRNA | BRD-K13185470 | CTRPv2 | pan-cancer | AAC | 0.27 | 3e-05 |
| mRNA | EX-527 | GDSC1000 | pan-cancer | AAC | 0.11 | 0.001 |
| mRNA | BRD-K34099515 | CTRPv2 | pan-cancer | AAC | 0.23 | 0.001 |
| mRNA | BRD-K50799972 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.002 |
| mRNA | QS11 | CTRPv2 | pan-cancer | AAC | 0.21 | 0.003 |
| mRNA | BRD-K27188169:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.14 | 0.006 |
| mRNA | Doxorubicin | gCSI | pan-cancer | AAC | -0.13 | 0.008 |
| mRNA | CAL-101 | GDSC1000 | pan-cancer | AAC | 0.081 | 0.008 |